RASAGILIN NOBEL cpr 1 mg 30 pce
7680677110016
CH-67711
N04BD02
01.08.0.
1 / 3
google
Details
- Product number
- 6771101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- rasagilinum 1 mg ut rasagilini mesilas, mannitolum, maydis amylum, amylum pregelificatum, silica colloidalis anhydrica, talcum, acidum stearicum, pro compresso.
Articles (1)
Rasagilin NOBEL 1 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 79.05
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2021
Authorization holder
NOBEL Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67711
- Drug name
- Rasagilin NOBEL, Tabletten
- Galenic form
- TAB
- ATC Code
- N04BD02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/05/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.08.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RASAGILIN NOBEL cpr 1 mg 30 pce
- Description (DE)
- RASAGILIN NOBEL Tabl 1 mg 30 Stk
- Market launch
- 18/05/2020
- Narcotic (BTM)
- No